Get the Stockscreener App
68.98
0.72%
0.49
After Hours:
68.98
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $68.98, with a volume of 6.05M.
It is up +0.72% in the last 24 hours and up +7.71% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$68.49
Open:
$68.68
24h Volume:
6.05M
Relative Volume:
0.64
Market Cap:
$81.29B
Revenue:
$378.96B
Net Income/Loss:
$5.28B
P/E Ratio:
16.46
EPS:
4.19
Net Cash Flow:
$5.94B
1W Performance:
+3.25%
1M Performance:
+7.71%
6M Performance:
+53.66%
1Y Performance:
+16.80%
1-Day Range:
$68.25
$69.17
1-Week Range:
$66.07
$69.17
52-Week Range:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
68.98 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
311.97 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
388.96 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
330.58 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
|
HUM
Humana Inc
|
244.48 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
North Star Investment Management Corp. Has $354,000 Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
Lawsuit says CVS crossed 'ethical and legal line' while fighting late change to pharmacy bill - WBRZ
Class action suit filed against CVS subsidiary for misuse of personal information - KLFY.com
Two Healthcare Heavyweights, One Winner: UnitedHealth or CVS Health? - Yahoo Finance
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025? - The Globe and Mail
Exploring CVS' Health Services Segment: A Key Growth Engine For 2025? - Barchart.com
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) - AOL.com
CVS Health (CVS) Faces Slight Dip After Recent Gains - GuruFocus
CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy? - Yahoo Finance
Wells Fargo Remains Bullish on CVS Health (CVS) With an $84 PT - Insider Monkey
Zacks Industry Outlook Highlights CVS Health, BrightSpring Health Services and GeneDx - Zacks Investment Research
Lesa Sroufe & Co Acquires Shares of 3,965 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Position Reduced by Birch Hill Investment Advisors LLC - MarketBeat
Brown Miller Wealth Management LLC Purchases Shares of 3,784 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Farmers & Merchants Investments Inc. - MarketBeat
15,438 Shares in CVS Health Co. (NYSE:CVS) Purchased by Krilogy Financial LLC - MarketBeat
HIV, AIDS Patients Denied Class Cert. In CVS Bias Fight - Law360
CVS Health stock rises after medicare PBM limits stripped from tax bill - Investing.com
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom - Yahoo Finance
Two Healthcare Heavyweights, One Winner: UnitedHealth Or CVS Health? - Barchart.com
Salem Investment Counselors Inc. Sells 47,415 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Fifth Third Bancorp Has $11.50 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
8,014 Shares in CVS Health Co. (NYSE:CVS) Acquired by Simon Quick Advisors LLC - MarketBeat
Mn Services Vermogensbeheer B.V. Sells 31,000 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Factory Mutual Insurance Co. Has $30.44 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Is the Artificial Intelligence Boost Fading for This Top Tech Stock? - The Motley Fool
CVS Health Co. (NYSE:CVS) Stock Holdings Trimmed by Coerente Capital Management - MarketBeat
Hennessy Advisors Inc. Grows Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health’s SWOT analysis: stock recovery potential amid sector challenges - Investing.com
Louisiana AG investigating CVS for sending mass text messages lobbying against legislation - Providence Business News
CVS Health Stock Sees Relative Strength Rating Rise To 78 - Investor's Business Daily
CVS Health blasts big pharma, praises Trump amid scrutiny of its own drug pricing practicesProvidence Business First - The Business Journals
CVS Wants To Halt Ark. Law Banning PBM-Owned Pharmacies - Law360
CVS Health Co. (NYSE:CVS) Stake Increased by Parkside Investments LLC - MarketBeat
Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis - Yahoo Finance
Avanza Fonder AB Has $6.22 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
KMG Fiduciary Partners LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Seeks Court-Ordered Pause on Embattled Arkansas Pharmacy Law - Bloomberg Law News
CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends? - Barchart.com
CVS Health Co. (NYSE:CVS) Shares Bought by Toth Financial Advisory Corp - MarketBeat
Is CVS Health Stock Outperforming the Nasdaq? - MSN
CVS vs. DHR: Which Stock Should Value Investors Buy Now? - Yahoo Finance
SG Americas Securities LLC Acquires 174,606 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Feds seek $706 million in penalties from Omnicare, CVS in False Claims Act case - McKnight's Senior Living
CVS Health: Seems Primed To Withstand Industry Woes (NYSE:CVS) - Seeking Alpha
CVS Settles Cigna Lawsuit Over Ex-Executive’s Noncompete Pact - Bloomberg Law News
CVS retains some liability in Omnicare false claims suit, federal judge says - McKnight's Senior Living
CVS Health Co. (NYSE:CVS) Shares Sold by Wesbanco Bank Inc. - MarketBeat
Government Seeks $706M Penalty in FCA Case Against Omnicare and CVS Health - USA Herald
Naples Global Advisors LLC Lowers Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvs Health Corp Stock (CVS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 02 '25 |
Sale |
67.86 |
2,276,068 |
154,444,758 |
9,670,731 |
| ROBBINS LARRY | Director |
May 05 '25 |
Sale |
67.41 |
1,323,932 |
89,249,945 |
8,346,799 |
| ROBBINS LARRY | Director |
May 06 '25 |
Sale |
66.67 |
150,000 |
10,000,710 |
8,196,799 |
| Shah Prem S | EVP and Group President |
Mar 17 '25 |
Option Exercise |
62.21 |
846 |
52,630 |
43,190 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Option Exercise |
62.21 |
7,513 |
467,384 |
15,907 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Sale |
66.35 |
7,513 |
498,488 |
8,394 |
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):